Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.tips.2021.11.010

http://scihub22266oqcxt.onion/10.1016/j.tips.2021.11.010
suck pdf from google scholar
34895944!ä!34895944
PDF vom PMID34895944  :  Publisher
PDF vom PMID34895944

suck abstract from ncbi

pmid34895944
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Deep mutational scanning for therapeutic antibody engineering #MMPMID34895944
  • Hanning KR; Minot M; Warrender AK; Kelton W; Reddy ST
  • Trends Pharmacol Sci 2022[Feb]; 43 (2): 123-135 PMID34895944show ga
  • The biophysical and functional properties of monoclonal antibody (mAb) drug candidates are often improved by protein engineering methods to increase the probability of clinical efficacy. One emerging method is deep mutational scanning (DMS) which combines the power of exhaustive protein mutagenesis and functional screening with deep sequencing and bioinformatics. The application of DMS has yielded significant improvements to the affinity, specificity, and stability of several preclinical antibodies alongside novel applications such as introducing multi-specific binding properties. DMS has also been applied directly on target antigens to precisely map antibody-binding epitopes and notably to profile the mutational escape potential of viral targets (e.g., SARS-CoV-2 variants). Finally, DMS combined with machine learning is enabling advances in the computational screening and engineering of therapeutic antibodies.
  • |*COVID-19[MESH]
  • |*SARS-CoV-2[MESH]
  • |Antibodies, Viral[MESH]
  • |Humans[MESH]
  • |Spike Glycoprotein, Coronavirus[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    123 2.43 2022